Related references
Note: Only part of the references are listed.Metabolic Codependencies in the Tumor Microenvironment
Prasenjit Dey et al.
CANCER DISCOVERY (2021)
Integrating metabolic reprogramming and metabolic imaging to predict breast cancer therapeutic responses
Yi Liu et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more
Xiaodong Hao et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma
Abudureyimu Tuerhong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
The enhancement of glycolysis regulates pancreatic cancer metastasis
Jinshou Yang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma
Laura L. Meijer et al.
ANNALS OF SURGERY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
Jia Liu et al.
NATURE COMMUNICATIONS (2020)
Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study)
Patrick Robelin et al.
GYNECOLOGIC ONCOLOGY (2020)
Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway
GuanXiong Ye et al.
CANCER BIOLOGY & THERAPY (2019)
MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1
Ying Yang et al.
NATURE COMMUNICATIONS (2019)
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial
Gayathri Anandappa et al.
CLINICAL CANCER RESEARCH (2019)
Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer
Yun Zhihua et al.
CANCER SCIENCE (2019)
PKM2, function and expression and regulation
Ze Zhang et al.
CELL AND BIOSCIENCE (2019)
New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism
Mjriam Capula et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
MiR-204-3p Inhibited the Proliferation of Bladder Cancer Cells via Modulating Lactate Dehydrogenase-Mediated Glycolysis
Jinan Guo et al.
FRONTIERS IN ONCOLOGY (2019)
Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2
Lu Chen et al.
ACTA PHARMACEUTICA SINICA B (2019)
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Abraham Pedroza-Torres et al.
FRONTIERS IN ONCOLOGY (2019)
Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3p
Sudeepti S. Kuppa et al.
CANCER LETTERS (2018)
LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis
Carmen Dorneburg et al.
CLINICAL CANCER RESEARCH (2018)
Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling
Ming-Chuan Hsu et al.
MOLECULAR CANCER (2018)
Tumor microenvironment participates in metastasis of pancreatic cancer
Bo Ren et al.
MOLECULAR CANCER (2018)
miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism
De-Hai Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Loss of MicroRNA-489-3p Promotes Osteosarcoma Metastasis by Activating PAX3-MET Pathway
Qifei Liu et al.
MOLECULAR CARCINOGENESIS (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer
Christopher J. Habrook et al.
CANCER CELL (2017)
PKM2, cancer metabolism, and the road ahead
Talya L. Dayton et al.
EMBO REPORTS (2016)
miR-489 Suppresses Proliferation and Invasion of Human Bladder Cancer Cells
Jing Li et al.
ONCOLOGY RESEARCH (2016)
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Yoav Binenbaum et al.
DRUG RESISTANCE UPDATES (2015)
Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up
Rushika M. Perera et al.
CANCER DISCOVERY (2015)
Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer
Jian Wang et al.
ONCOTARGET (2015)
Role of MicroRNAs in the Warburg Effect and Mitochondrial Metabolism in Cancer
Hui-Jin Li et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Metabolism addiction in pancreatic cancer
R. Blum et al.
CELL DEATH & DISEASE (2014)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
MicroRNA Functions in Stress Responses
Anthony K. L. Leung et al.
MOLECULAR CELL (2010)
MicroRNA-451 Regulates LKB1/AMPK Signaling and Allows Adaptation to Metabolic Stress in Glioma Cells
Jakub Godlewski et al.
MOLECULAR CELL (2010)
p53 represses c-Myc through induction of the tumor suppressor miR-145
Mohit Sachdeva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Share Paper
